The Birth of Masimo: How Project Stork and SET® Pulse Oximetry Revolutionized Neonatal Care

Learn how Masimo Founder and CEO Joe Kiani took his dream of advancing pulse oximetry & turned it into a global company with more than 5,500 people dedicated to improving patient outcomes. With Project Stork and the development of SET® Measure-through Motion and Low Perfusion™ pulse oximetry, Masimo solved seemingly unsolvable problems and made a significant impact on neonatal care, helping clinicians reduce the incidence of retinopathy of prematurity (ROP) and improve critical congenital heart disease (CCHD) screening. With contributions from Joe Kiani, COO Bilal Muhsin, Dr. Mitch Goldstein, Dr. Vijay Dhar, and more.
To learn more about Masimo SET®, visit bit.ly/2YIqxHc

[@masimo_spo2]

Masimo’s birth is nice

[@FranciscoVilla-zj7dr]

🙌🏽🙌🏽🙌🏽

[@Bun_the_bumble]

How come I never heard of this?

[@kornbob2665]

✌️